October 27, 2023 01:33 PM EDT
Pharma
FDA+

CMS to kick off Medicare drug price ne­go­ti­a­tion lis­ten­ing ses­sions next week

Lia DeGroot

As CMS and phar­ma com­pa­nies pre­pare to hash out the first round of Medicare drug price ne­go­ti­a­tion pro­vi­sions of the In­fla­tion Re­duc­tion Act, CMS will …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three Dyne ex­ec­u­tives leave as com­pa­ny re­ports new Duchenne drug da­ta

With few specifics, Re­cur­sion un­der­whelms with first Phase 2 read­out, but ‘plans to ad­vance’ drug

Dana-Far­ber chief Lau­rie Glim­ch­er set to leave sto­ried can­cer cen­ter

Pfiz­er and Val­ne­va say sec­ond Ly­me boost­er led to 'strong' re­spons­es, tar­get 2026 FDA sub­mis­sion

Ex­clu­sive: Duke spin­out launch­es in hopes of pre­vail­ing with brain can­cer bis­pe­cif­ic where Am­gen, Roche did not

sponsored

How to se­cure full en­roll­ment and a 30x ROI: A con­ver­sa­tion with the CEO of the bou­tique en­roll­ment agency do­ing just ...

A service from the Financial Times